Alkermes Plc (ALKS)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Alkermes Plc (ALKS)
Go deeper and ask any question about ALKS
Company Performance
Current Price
as of Sep 18, 2024$27.83
P/E Ratio
16.49
Market Cap
$4.58B
Description
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.
Metrics
Overview
- HQDublin, DU
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerALKS
- Price$27.83+0.32%
Trading Information
- Market Cap$4.58B
- Float98.12%
- Average Daily Volume (1m)1,345,312
- Average Daily Volume (3m)1,784,903
- EPS$1.72
Company
- Revenue$1.51B
- Rev Growth (1yr)-35.35%
- Net Income$94.66M
- Gross Margin84.24%
- EBITDA Margin29.20%
- EBITDA$116.54M
- EV$3.61B
- EV/Revenue2.40
- P/E16.49
- P/S3.16
Documents
SEC Filings
Factset Street Account
Factset